Incremental cost-effectiveness of the second Xpert MTB/RIF assay to detect Mycobacterium tuberculosis

BACKGROUND: Due to the non-homogeneity of specimens collected from tuberculosis (TB) suspects, repeated Xpert MTB/RIF (Xpert) may have potential clinical benefits. Incremental cost-effectiveness was analyzed for the second Xpert assay to detect Mycobacterium tuberculosis (Mtb) and rifampicin (RIF) r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thorac Dis
Hlavní autoři: Wang, Guirong, Wang, Shuqi, Jiang, Guanglu, Fu, Yuhong, Shang, Yuanyuan, Huang, Hairong
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5906334/
https://ncbi.nlm.nih.gov/pubmed/29707322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.02.60
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky